🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Germany / NCT03547947
Active, not recruiting Observational

Clinical and Radiological Outcomes of Medacta Shoulder System

NCT03547947 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2018-06-13
Last updated
2025-09-29

Condition(s) studied

Primary OsteoarthritisSecondary OsteoarthritisRotator Cuff Tear ArthropathyRheumatoid Arthritis ShoulderAvascular NecrosisFractureRevision of Shoulder Arthroplasty

Investigational drug(s) / intervention(s)

Medacta Shoulder System

Medacta Shoulder System: Total Shoulder Arthroplasty

Study summary

This is a post-marketing surveillance on Medacta Shoulder System

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients older than 18 years * Patient with one of the following diagnosis: Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (\<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty Exclusion Criteria: * Patients with malignant diseases (at the time of surgery) * Patients with proven or suspect infections (at the time of surgery) * Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery) * Patients with known incompatibility or allergy to products materials (at the time of surgery)

Primary outcome measure(s)

Trial sites (6)

FacilityCityRegionStatus
Clinique du Sport et de Chirurgie Orthopédique Marcq-en-Barœul France
Klinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation München Germany
Orthopädie Sonnenhof Bern Canton of Bern
Inselspital Bern Switzerland
Lindenhofspital Bern Switzerland
Klinik für Orthopädische Chirurgie und Traumatologie des Bewegungsapparates, Kantonsspital St.Gallen, Sankt Gallen Switzerland

More Medacta International SA trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03547947 on ClinicalTrials.gov ↗ ← All trials in Germany